APOE E4 carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10

Neuropsychopharmacology

Volumn 38, Issue 4, 2013, Pages 655-663

  Evans, Simon ^a   Gray, Marcus A ^b,c   Dowell, Nicholas G ^d   Tabet, Naji ^d   Tofts, Paul S ^d   King, Sarah L ^a   Rusted, Jennifer M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Alzheimer's disease; APOE; imaging; learning and memory; nicotine; psychopharmacology

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; NICOTINE;

ADULT; ARTICLE; COGNITION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HIPPOCAMPUS; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE MEMORY; REACTION TIME;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; APOLIPOPROTEIN E4; BRAIN; FEMALE; HETEROZYGOTE; HUMANS; MALE; MEMORY, EPISODIC; NICOTINE; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 84873726834     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.230     Document Type: Article

References (66)

1. Adda CC, Castro LH, Alem-Mar e Silva LC, de Manreza ML, Kashiara R (2008). Prospective memory and mesial temporal epilepsy associated with hippocampal sclerosis. Neuropsychologia 46: 1954-1964.
2. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D et al (1997). Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17: 516-529.
3. Bentley P, Driver J, Dolan RJ 2011). Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging. Prog Neurobiol 94: 360-388.
4. Bisley JW, Goldberg ME (2010). Attention, intention, and priority in the parietal lobe. Annu Rev Neurosci 33: 1-21.
5. Bloss CS, Delis DC, Salmon DP, Bondi MW (2010). APOE genotype is associated with left-handedness and visuospatial skills in children. Neurobiol Aging 31: 787-795.
6. Bondi MW, Houston WS, Eyler LT, Brown GG (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64: 501-508.
7. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC et al (2000). Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343: 450-456.
8. Borghesani PR, Johnson LC, Shelton AL, Peskind ER, Aylward EH, Schellenberg GD et al (2008). Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. Neurobiol Aging 29: 981-991.
9. Braak H, Braak E (1997). Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 18(4 Suppl): S85-S88.
10. Bunge SA, Hazeltine E, Scanlon MD, Rosen AC, Gabrieli JD (2002). Dissociable contributions of prefrontal and parietal cortices to response selection. Neuroimage 17: 1562-1571.
11. Burgess PW, Gilbert SJ, Dumontheil I (2007). Function and localization within rostral prefrontal cortex (area 10). Philos Trans R Soc Lond B Biol Sci 362: 887-899.
12. Burgess PW, Gonen-Yaacovi G, Volle E 2011). Functional neuroimaging studies of prospective memory: what have we learnt so far? Neuropsychologia 49: 2246-2257.
13. Burgess PW, Quayle A, Frith CD (2001). Brain regions involved in prospective memory as determined by positron emission tomography. Neuropsychologia 39: 545-555.
14. Burgess PW, Scott SK, Frith CD (2003). The role of the rostral frontal cortex (area 10) in prospective memory: a lateral versus medial dissociation. Neuropsychologia 41: 906-918.
15. Chen AJ, Britton M, Turner GR, Vytlacil J, Thompson TW, D'Esposito M (2012). Goal-directed attention alters the tuning of object-based representations in extrastriate cortex. Front Hum Neurosci 6: 187.
16. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF et al (2002). Cognitive change and the APOE epsilon 4 allele. Nature 418: 932.
17. Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, Welsh-Bohmer KA et al (2010). Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement 6: 303-311.
18. Driscoll I, McDaniel MA, Guynn MJ (2005). Apolipoprotein E and prospective memory in normally aging adults. Neuropsychology 19: 28-34.
19. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K et al (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25: 1325-1335.
20. Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE et al (2001). Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA 98: 4728-4733.
21. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK et al 2011). Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 54: 602-610.
22. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM et al (2009). Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 106: 7209-7214.
23. Fleisher AS, Sherzai A, Taylor C, Langbaum JB, Chen K, Buxton RB (2009). Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage 47: 1678-1690.
24. Friston KJ, Zarahn E, Josephs O, Henson RN, Dale AM (1999). Stochastic designs in event-related fMRI. Neuroimage 10: 607-619.
25. Furey ML, Pietrini P, Haxby JV (2000). Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290: 2315-2319.
26. Ghatan PH, Ingvar M, Eriksson L, Stone-Elander S, Serrander M, Ekberg K et al (1998). Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology (Berl) 136: 179-189.
27. Giessing C, Fink GR, Rosler F, Thiel CM (2007). fMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis. J Cogn Neurosci 19: 658-670.
28. Gilbert SJ, Gollwitzer PM, Cohen AL, Burgess PW, Oettingen G (2009). Separable brain systems supporting cued versus self-initiated realization of delayed intentions. J Exp Psychol Learn Mem Cogn 35: 905-915.
29. Greenwood PM, Lambert C, Sunderland T, Parasuraman R (2005a). Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study. Neuropsychology 19: 199-211.
30. Greenwood PM, Sunderland T, Putnam K, Levy J, Parasuraman R (2005b). Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: results from the NIMH BIOCARD study. Neuropsychology 19: 830-840.
31. Greicius MD, Krasnow B, Reiss AL, Menon V (2003). Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 100: 253-258.
32. Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA (2007). Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 27: 3477-3489.
33. Han SD, Bondi MW (2008). Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 4: 251-254.
34. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS et al (2007). Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging 28: 238-247.
35. Hubacek JA, Pitha J, Skodova Z, Adamkova V, Lanska V, Poledne R (2001). A possible role of apolipoprotein E polymorphism in predisposition to higher education. Neuropsychobiology 43: 200-203.
36. Kumari V, Gray JA, ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E et al (2003). Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 19: 1002-1013.
37. Lawrence NS, Ross TJ, Stein EA (2002). Cognitive mechanisms of nicotine on visual attention. Neuron 36: 539-548.
38. Mahley RW (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
39. Marchant NL, King SL, Tabet N, Rusted JM (2010). Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology 35: 1090-1096.
40. Marchant NL, Trawley S, Rusted JM (2008). Prospective memory or prospective attention: physiological and pharmacological support for an attentional model. Int J Neuropsychopharmacol 11: 401-411.
41. Martin T, McDaniel MA, Guynn MJ, Houck JM, Woodruff CC, Bish JP et al (2007). Brain regions and their dynamics in prospective memory retrieval: a MEG study. Int J Psychophysiol 64: 247-258.
42. Mason MF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN (2007). Wandering minds: the default network and stimulus-independent thought. Science 315: 393-395.
43. Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF et al (2007). Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 17: 1934-1947.
44. Nelson HE (1982). The National Adult Reading Test (NART): Test Manual. NFER-Nelson: Windsor.
45. Nobre AC, Allison T, McCarthy G (1998). Modulation of human extrastriate visual processing by selective attention to colours and words. Brain 121, (Pt 7) 1357-1368.
46. Parasuraman R, Greenwood PM, Sunderland T (2002). The apolipoprotein E gene, attention, and brain function. Neuropsychology 16: 254-274.
47. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D et al (1995). Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 92: 12260-12264.
48. Rocchi A, Pellegrini S, Siciliano G, Murri L (2003). Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61: 1-24.
49. Ruest T, Dowell NG, Evans SL, King SL, Tabet N, Tofts P (under review) MR imaging of carriers of the apolipoprotein E e4 allele-evidence for structural differences in normal appearing brain tissue in e4\+ compared to e4-young adults.
50. Rusted J, Ruest T, Gray MA 2011). Acute effects of nicotine administration during prospective memory, an event related fMRI study. Neuropsychologia 49: 2362-2368.
51. Rusted JM, Sawyer R, Jones C, Trawley SL, Marchant NL (2009). Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology (Berl) 202: 93-102.
52. Rusted JM, Trawley S, Heath J, Kettle G, Walker H (2005). Nicotine improves memory for delayed intentions. Psychopharmacology (Berl) 182: 355-365.
53. Rusted JM, Warburton DM (1989). Effects of scopolamine on verbal memory; a retrieval or acquisition deficit? Neuropsychobiology 21: 76-83.
54. Sarter M, Gehring WJ, Kozak R (2006). More attention must be paid: The neurobiology of attentional effort. Brain Res Rev 51: 145-160.
55. Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO (1996). Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clin Pharmacokinet 31: 65-80.
56. Sheline YI, Morris JC, Snyder AZ, Price JL, Yan Z, D'Angelo G et al (2010). APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. J Neurosci 30: 17035-17040.
57. Simons JS, Scholvinck ML, Gilbert SJ, Frith CD, Burgess PW (2006). Differential components of prospective memory? Evidence from fMRI. Neuropsychologia 44: 1388-1397.
58. Tanabe J, Nyberg E, Martin LF, Martin J, Cordes D, Kronberg E et al 2011). Nicotine effects on default mode network during resting state. Psychopharmacology (Berl) 216: 287-295.
59. Thiel CM, Fink GR (2008). Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control. Neuroscience 152: 381-390.
60. Thiel CM, Zilles K, Fink GR (2005). Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology 30: 810-820.
61. Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP et al (2012a). The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease. Neurobiol Aging 33: 618 e611-618 e613.
62. Trachtenberg AJ, Filippini N, Ebmeier KP, Smith SM, Karpe F, Mackay CE (2012b). The effects of APOE on the functional architecture of the resting brain. Neuroimage 59: 565-572.
63. Westlye ET, Lundervold A, Rootwelt H, Lundervold AJ, Westlye LT 2011). Increased hippocampal default mode synchronization during rest in middle-aged and elderly APOE epsilon4 carriers: relationships with memory performance. J Neurosci 31: 7775-7783.
64. Yu AJ, Dayan P (2005). Uncertainty, neuromodulation, and attention. Neuron 46: 681-692.
65. Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ (2000). Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 294: 179-181.
66. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA (2008). Metaanalysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 25: 279-290.